Pervin Soyer

Dr. Pervin Soyer

Department of Pharmaceutical Microbiology, Anadolu University Faculty of Pharmacy, Eskişehir, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2019 in Journal of the Turkish Chemical Society Section A: Chemistry
Verified
Journal Article
Open access
PDF file
SKSevim Küçük
Sevim Küçük
PSPervin Soyer
Pervin Soyer
YTYağmur TUNALI
Yağmur TUNALI
In the present study, Salvia sclarea L. was collected during to flowering stage in 2016, Sarıcakaya (Eskişehir/Turkey) and dried medicinal plant materials were macerated with 70% MeOH. The antimicrobial activity of Salvia sclarea extracts was determined with minimum inhibitory concentration (MIC) assay against Escherichia coli ATCC 35218, Staphylococcus aureus ATCC 29213 and Candida albicans ATCC 90028. The antibiofilm activity of Salvia sclarea extracts was determined against Staphylococcus aureus ATCC 29213 and Staphylococcus epidermidis ATCC 14990. And the preliminary cytotoxicity assessment of extracts was tested with Brine Shrimp Lethality Assay against model organism Artemia salina nauplii. As a result, Salvia sclarea extract showed remarkably antibacterial activity while it showed no effect on Candida albicans ATCC 90028. Moreover, antibiofilm activity could not be determined. The lethality effect also could not be determined due to high dose concentrations.

29 August 2024 in International Journal of Secondary Metabolite
Verified
Journal Article
Open access
PDF file
PSPervin Soyer
Pervin Soyer
SKSevim Küçük
Sevim Küçük
YTYağmur Tunalı
Yağmur Tunalı
The consumption of traditional medicinal herbs has gained popularity as a viable alternative approach for addressing microbial infections or infectious structures. In this study, Verbascum detersile, Verbascum eskisehirensis, and Verbascum gypsicola endemic species belonging to the Scrophulariaceae family, spreading in Eskişehir and its surroundings, were collected from natural habitats and evaluated in terms of antimicrobial and antibiofilm activities. In biological activity studies, different concentrations of three plant extracts showed various antimicrobial and antibiofilm activities on selected standard microorganism cultures (Staphylococcus aureus ATCC 29213, Staphylococcus epidermidis ATCC 14990, Pseudomonas aeruginosa ATCC 27853, Candida albicans ATCC 90028, and Candida krusei ATCC 6258). It was observed that the selected three endemic Verbascum extracts had a minimum inhibitory and minimum biofilm eradication concentration value of 1250 μg/mL.

23 June 2020 in Journal of the Turkish Chemical Society Section A: Chemistry
Verified
Journal Article
Open access
PDF file
PSPervin Soyer
Pervin Soyer
YTYağmur TUNALI
Yağmur TUNALI
Actinomycetes bacterial group has the one of the most populous population in microorganisms that extends very different and extensive habitats on earth especially main character of the natural soil habitats. Since old times, bioactive metabolites of soil microorganisms have studied and the results have provided that metabolites these microorganisms have significant benefits to science, medicine, agriculture and pharmaceutical industry. In this study, isolation of Actinomycetes strains from forest soils, identification of morpohological and molecular features, extraction the bioactive metabolite of isolates and determination the antimicrobial, antibiofilm and cytotoxicity activities of bioactive extract was tested. The microbiological isolation methods for collected forest soil samples were used and after the determination of their morphological and molecular features, isolates were defined as Brevibacterium spp. that is member of Actinomycetes. The antibiotic resistance of the isolates were determined by different methods and different concentrations of standard antibiotics. The chromium tolerance of isolates were also determined. The bioactive metabolites of isolates were produced in modified medium and extracted. The antimicrobial, antibiofilm, cytotoxicity activities of bioactive metabolite were determined against standard microorganisms and Artemia salina larvae were used as test organism for cytotoxicity tests. In the present study, results gave informations about Actinomycetes that isolated from forest soils. Isolates have antibiotic resistance and chromium tolerance abilities. And also, showed, Actinomycetes group is the largest bioactive metabolite producing group both antibacterial, antifungal and also a wide range of other compounds such as antibiofilm and cytotoxic compounds. The antimicrobial (MIC) concentrations of bioactive metabolite 2500 μg/mL for standard bacteria cultures and 1250 μg/mL for yeasts. The antibiofilm (MBEC) value was determined at 1250 μg/mL. The 2500 μg/mL concentration of extract was found the effective cytotoxic value. The results are provided that the Brevibacterium spp. isolates have industrial and pharmaceutical potential and more detailed pharmaceutical researchs are planned.


24 April 2023 in European Journal of Life Sciences
Verified
Journal Article
Open access
PDF file
PSPervin Soyer
Pervin Soyer
MTMelek Tekgöz
Melek Tekgöz
YTYağmur Tunalı
Yağmur Tunalı
Colostrum milk has been used as a source for isolating many probiotic bacteria since it contains many helpful probiotic microorganisms. Because of the huge microorganism diversity and functionality of colostrum, there is opportunity to isolate bacteria and analyze their probiotic potential. Comparing the diversity of probiotic bacteria in milk from postpartum periods is also crucial. In the current study, Lactic Acid Bacteria (LAB) cultures were isolated from cow colostrum milk. The 28 cultures were isolated, but only 2 were characterized as LAB by their colony and molecular characterization, Gram nature, catalase, antibiotics, and pepsin tolerance. As a result of molecular identification tests, the isolates were identified as Lactobacillus casei and Lactobacillus paracasei with 99-100% homology. These two isolates could survive in the presence of gastric and intestinal conditions. These isolates also showed antimicrobial and antioxidant activities. The results demonstrated that LAB species isolated from colostrum milk exhibited promising probiotic properties and seemed favorable for use in pharmaceuticals and foods.

9 August 2026 in Food Science & Nutrition
Verified
Journal Article
Open access
PDF file
PSPervin Soyer
Pervin Soyer
A. Alper ÖztürkA. Alper Öztürk
A. Alper Öztürk
Oral microbiome dysbiosis is associated with biofilm‐related diseases, including dental caries and periodontal infections. This study aimed to develop and evaluate a pharmabiotic oral spray containing microencapsulated Lactiplantibacillus pentosus, sodium hyaluronate, and licorice ( Glycyrrhiza glabra ) extract to support oral microbial homeostasis. L. pentosus was microencapsulated by freeze‐drying using maltodextrin and gum arabic as wall materials. The microencapsulation process resulted in an encapsulation efficiency of 94.74% ± 1.12% and a post‐encapsulation viability of 8.17 ± 0.05 log CFU/mL. Four oral spray formulations (F1–F4) were prepared and evaluated for antimicrobial, antibiofilm, antioxidant, physicochemical, microbiological, and stability properties. All formulations exhibited antibacterial activity against Gram‐positive oral pathogens, particularly Streptococcus mutans and Staphylococcus aureus , while no inhibitory activity was observed against Pseudomonas aeruginosa or Candida species. Antibiofilm analysis demonstrated substantial inhibition, ranging from 56.17% ± 0.91% to 70.99% ± 1.32% against S. mutans and from 72.42% ± 0.56% to 87.03% ± 1.76% against S. aureus . Antioxidant assays (DPPH, ABTS, and ORAC) confirmed moderate and consistent antioxidant activity across all formulations. During 3 months of storage, probiotic viability remained above 10 8 CFU/mL in most formulations. Viability losses under refrigerated conditions were limited to approximately 0.38–0.50 log CFU/mL, while formulation F2 retained 8.42 ± 0.14 log CFU/mL under accelerated conditions. Among the tested formulations, F1 exhibited the most favorable overall physicochemical characteristics and stability profile. These findings demonstrate that the developed oral spray represents a promising pharmabiotic delivery system combining probiotic viability, antibiofilm activity, and antioxidant potential for supporting oral health and microbial balance.